Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5608
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance ; day:14 ; month:8 ; year:2018 ; pages:1-7
Prostate cancer and prostatic diseases ; (14.8.2018), 1-7
- Creator
-
Borque-Fernando, Ángel
- Contributor
-
Rubio-Briones, José
Esteban, Luis M.
Dong, Yan
Calatrava, Ana
Gómez-Ferrer, Álvaro
Gómez-Gómez, Enrique
Gil Fabra, Jesús M.
Rodríguez-García, Nuria
López González, Pedro Á
García-Rodríguez, Jorge
Rodrigo-Aliaga, Miguel
Herrera-Imbroda, Bernardo
Soto-Villalba, Juan
Martínez-Breijo, Sara
Hernández-Cañas, Virginia
Soto-Poveda, Ana M.
Sánchez-Rodríguez, Carlos
Carrillo-George, Carlos
Hernández-Martínez, Yumaira E.
Okrongly, David
SpringerLink (Online service)
- DOI
-
10.1038/s41391-018-0074-5
- URN
-
urn:nbn:de:101:1-2018101200025733500418
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borque-Fernando, Ángel
- Rubio-Briones, José
- Esteban, Luis M.
- Dong, Yan
- Calatrava, Ana
- Gómez-Ferrer, Álvaro
- Gómez-Gómez, Enrique
- Gil Fabra, Jesús M.
- Rodríguez-García, Nuria
- López González, Pedro Á
- García-Rodríguez, Jorge
- Rodrigo-Aliaga, Miguel
- Herrera-Imbroda, Bernardo
- Soto-Villalba, Juan
- Martínez-Breijo, Sara
- Hernández-Cañas, Virginia
- Soto-Poveda, Ana M.
- Sánchez-Rodríguez, Carlos
- Carrillo-George, Carlos
- Hernández-Martínez, Yumaira E.
- Okrongly, David
- SpringerLink (Online service)
Other Objects (12)
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
The utility of prostate MRI within active surveillance: description of the evidence
Risk of progression following a negative biopsy in prostate cancer active surveillance
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies
Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
The utility of prostate MRI within active surveillance: description of the evidence
Risk of progression following a negative biopsy in prostate cancer active surveillance
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies
Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
The utility of prostate MRI within active surveillance: description of the evidence
Risk of progression following a negative biopsy in prostate cancer active surveillance
Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies